Market closed
Journey Medical Corporation/$DERM
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Journey Medical Corporation
Journey Medical Corp is a commercial stage pharmaceutical company focused on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions. The company's current product portfolio includes eight FDA-approved prescription drugs for dermatological conditions that are marketed in the U.S. Some of the group's products are Qbrexza, Accutane, Amzeeq, Exelderm and others.
Ticker
$DERM
Sector
Trading on
Industry
Pharmaceuticals
Headquarters
Employees
41
Website
DERM Metrics
BasicAdvanced
$143M
-
-$0.72
0.91
-
Price and volume
Market cap
$143M
Beta
0.91
52-week high
$7.29
52-week low
$4.97
Average daily volume
84K
Financial strength
Current ratio
1.37
Quick ratio
0.868
Long term debt to equity
124.555
Total debt to equity
128.083
Interest coverage (TTM)
-5.07%
Management effectiveness
Return on assets (TTM)
-10.88%
Return on equity (TTM)
-72.60%
Valuation
Price to revenue (TTM)
2.26
Price to book
6.86
Price to tangible book (TTM)
-11.66
Price to free cash flow (TTM)
-5.259
Growth
Revenue change (TTM)
-29.11%
Earnings per share change (TTM)
239.81%
3-year revenue growth (CAGR)
-3.84%
3-year earnings per share growth (CAGR)
-45.02%
DERM News
AllArticlesVideos
Journey Medical Corporation Appoints Ramsey Alloush as Chief Operating Officer
GlobeNewsWire·2 weeks ago
Journey Medical Corporation (DERM) Q4 2024 Earnings Call Transcript
Seeking Alpha·3 weeks ago
Journey Medical Corporation Reports Full-Year 2024 Financial Results and Recent Corporate Highlights
GlobeNewsWire·3 weeks ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs
What’s the current market cap for Journey Medical Corporation stock?
Journey Medical Corporation (DERM) has a market cap of $143M as of April 18, 2025.
What is the P/E ratio for Journey Medical Corporation stock?
The price to earnings (P/E) ratio for Journey Medical Corporation (DERM) stock is 0 as of April 18, 2025.
Does Journey Medical Corporation stock pay dividends?
No, Journey Medical Corporation (DERM) stock does not pay dividends to its shareholders as of April 18, 2025.
When is the next Journey Medical Corporation dividend payment date?
Journey Medical Corporation (DERM) stock does not pay dividends to its shareholders.
What is the beta indicator for Journey Medical Corporation?
Journey Medical Corporation (DERM) has a beta rating of 0.91. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.